VENUSREMNSEVenus Remedies Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 8 Jul · 10:26 IST

Venus Remedies Limited has informed the Exchange regarding compliance under regulation 74(5) of SEBI DP regulations for the quarter ended on 30th June 2025.

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Venus Remedies has submitted a routine compliance certificate under SEBI's Depositories and Participants Regulations to both NSE and BSE. The certificate, issued by its Registrar & Transfer Agent MUFG Intime India Pvt Ltd, confirms that all share dematerialization requests received from depository participants during the quarter ending 30 June 2025 were processed and confirmed to the depositories within the prescribed timelines. Cancelled physical certificates were mutilated and the depository's name was substituted as the registered owner in the company's register of members. There are no changes to shareholding, capital structure, or business operations disclosed in this filing.

Likely market impact

No material impact on shareholders or stock price. This is a standard quarterly procedural filing required by SEBI and carries no new financial or strategic information for investors.